Authors
AR de Castella, Michael Berk, P Fitzgerald, S Filia, K Filia, S Tahtalian, Seetal Dodd, P Callaly, Lesley Berk, K Kelin, M Smith, A Brnabic, AJ Lowry, W Montgomery, J Kulkarni
Publication date
2006/12
Journal
Acta Neuropsychiatrica
Volume
18
Issue
6
Pages
325-325
Publisher
Cambridge University Press
Description
Objective:
The Bipolar Comprehensive Outcomes Study (BCOS) is an ongoing, Australian, 2-year, observational study of participants with bipolar I or schizoaffective disorder, designed to examine the economic, clinical and functional outcomes associated with treatment in a ‘real-life’context.
Methods:
Participants prescribed olanzapine or conventional mood stabilizers were assessed at entry using the Young Mania Rating Scale (YMRS), Hamilton Depression Rating Scale (HAMD21), Clinical Global Impressions Scale–Bipolar Version (CGI-BP) and the EuroQol Instrument.
Results:
On average, participants were 41.8±12.7 years of age. About 58%(n= 140) were women, and 73%(n= 176) had a diagnosis of bipolar I disorder. Olanzapine was prescribed to 35%(n= 85) of participants, and more commonly for schizoaffective disorder (48% vs. 31% for bipolar). Based on CGI-BP scores, more women were markedly ill (34 …
Scholar articles
AR de Castella, M Berk, P Fitzgerald, S Filia, K Filia… - Acta Neuropsychiatrica, 2006